-
Although widespread screening mammography has greatly increased the diagnosis of early breast cancer, it has had only a marginal effect on the diagnosis of late-stage tumors and breast cancer mortality.
-
The authors concluded that compared to beta-blockers, the risk of angioedema is highest with ACEIs or aliskiren and lowest with ARBs.
-
The first inhibitor of the microsomal triglyceride transport protein (MTP) has been approved for the treatment of homozygous familial hypercholesterolemia (HoFH).
-
During family discussions, physicians who believe more strongly that life support should be withdrawn are more likely to present the option of comfort care and describe its benefits.
-
CKD: Consistency of GFR and Albuminuria as Risk Predictors; Changing Outcomes for Patients with Chronic Hepatitis C; Is Fructose a Primary Culprit in Obesity?
-
Insomnia is a common complaint among adults and it is well recognized that mental performance can be impaired by poor sleep. Both difficulty falling asleep and trouble staying asleep have been associated with poor cognitive function in cross-sectional elderly cohorts.
-
Our Newest Pharmacologic Class for Treatment of Diabetes: SGLT2 Inhibitors
-
This cross-sectional studys purpose was to validate the Male Osteoporosis Risk Estimation Score (MORES) in a primary care setting; it had been previously validated in the National Health and Nutrition Examination Survey (NHANES) III.
-
Fluoroquinolones are commonly prescribed bactericidal agents with a wide spectrum of activity. In addition to the coverage against conventional gram-negative organisms, newer agents in this class have an expanded spectrum of activity against a variety of gram-positive and atypical organisms.
-
Dolutegravir, a once daily hiv-1 integrase strand transfer inhibitor (INSTI), has been approved by the FDA.
